Brought to you by 
Aegerion Pharmaceuticals raises funds
29 Oct 2008
Executive Summary
Since refiling to go public in November 2007, Aegerion Pharmaceuticals (cardiovascular and metabolic therapeutics) has gone ahead and raised an undisclosed amount of funding from inside investors to pay for current and upcoming clinical trials.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Financing
- Private Placement
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com